Sign in
4

Changes in Ownership

Bone Biologics Corp Filed Acc 0001209191-15-087460

Options or other derivatives

  • Chief Technology Officer acquired 799,414 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Treat William Jay · Chief Technology Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2015-12-28 Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) +799,414 799,414 D
Loading xslF345X03/doc4.xml…